She made several varieties of the thin, crispy cookie in a factory next door to her North Carolina home, and sold 10 million of them a year.
Tag: Family Business
German Businesses Bet Big on China, and They’re Starting to Worry
Geopolitical risks have exposed long-ignored strains on Germany’s socioeconomic model. The family businesses underpinning its economy are seeking a new path.
He Ran Sudan’s Iconic Acropole Hotel. Then He Had to Flee Khartoum.
Thanasis Pagoulatos led the family business, Khartoum’s oldest inn, through decades of tumult. Sudan’s latest breakdown proved too much.
Heat Pump Maker’s $13.3 Billion Sale Raises Questions in Germany
Carrier Global Corp., plans to acquire a unit of Viessmann Group that produces heat pumps, seen in Berlin as the heating solution for Germany’s green future.
Berlin to Review Sale of Heat Pump Maker to U.S. Firm
Carrier Global Corp., plans to acquire a unit of Viessmann Group that produces heat pumps, seen in Berlin as the heating solution for Germany’s green future.
He’s the Brusque Mr. Fix-It for Mexico City’s Accordions
For 50 years, Francisco Luis Ramírez has been the go-to guy for instrument repairs in a nation that reveres the accordion. Now it’s a family business.
The World Needs Syringes. He Jumped In to Make 5,900 Per Minute.
Rajiv Nath’s family-run Hindustan Syringes bets it can help meet the pandemic need for billions of barrels and needles.
Elaine Chao’s Mix of Work and Family Drew Early Ethics Scrutiny
An inspector general’s report provided new details of how ethics lawyers at the Transportation Department raised flags starting in 2017 about efforts to promote her family and its shipping business.
This Japanese Shop Is 1,020 Years Old. It Knows a Bit About Surviving Crises.
A mochi seller in Kyoto, and many of Japan’s other centuries-old businesses, have endured by putting tradition and stability over profit and growth.
Indian Billionaires Bet Big on Head Start in Coronavirus Vaccine Race
The world’s largest vaccine producer, the Serum Institute, announced a plan to make hundreds of millions of doses of an unproven inoculation. It’s a gamble with a huge upside. And huge risks.